X-VAX TECHNOLOGY
X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response – so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.
X-VAX TECHNOLOGY
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.x-vax.com
Total Employee:
11+
Status:
Active
Total Funding:
56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Rapid Novor
Rapid Novor is a biotech company dedicated to advance next-generation protein sequencing technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Employees Featured
Founder
Investors List
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series A - X-Vax Technology
Founders Fund
Founders Fund investment in Series A - X-Vax Technology
Adjuvant Capital
Adjuvant Capital investment in Series A - X-Vax Technology
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Series A - X-Vax Technology
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - X-Vax Technology
Connectivity Ventures Fund
Connectivity Ventures Fund investment in Series A - X-Vax Technology
Helicase Venture
Helicase Venture investment in Series A - X-Vax Technology
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Series A - X-Vax Technology
Official Site Inspections
http://www.x-vax.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.91 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "X-Vax Technology"
X-Vax Company Profile 2024: Valuation, Funding
X-Vax General Information Description. Operator of a biotechnology company intended to develop vaccines against pathogens acquired by a mucosal infection. The company develops a herpes vaccine candidate which is based on an …See details»
X-Vax Technology Inc - Company Profile and News
X-Vax Technology, Inc. operates as a biotechnology company. The Company develops and commercializes therapies and vaccines against pathogens acquired by mucosal infection such …See details»
X-Vax Technology - Funding, Financials, Valuation & Investors
X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. Search Crunchbase. ... How much funding has this …See details»
X-Vax Technology Company Profile: Overview and Full News Analysis
X-Vax Technology's primary product line includes vaccines designed to target specific pathogens and provide immunity against infectious diseases. One of the key products offered by X-Vax …See details»
X-Vax Technology, Inc. Asset Profile | Preqin
Founded in 2015 and based in Florida, US, X-Vax Technology, Inc. is a biotechnology company for the preclinical and clinical development of vaccines against pathogens that cause mucosal …See details»
X-Vax Technology, Inc. | LinkedIn
X-Vax Technology, Inc. | 499 seguidores en LinkedIn. Beating herpes. A new approach to creating a world-changing vaccine. | We’re a biotech company committed to developing …See details»
X-Vax Technology, Inc. - Drug pipelines, Patents, Clinical trials
Explore X-Vax Technology, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news. Explore X-Vax Technology, Inc. with its drug pipeline, therapeutic area, technology …See details»
X-Vax Technology Inc. - BioCentury Company Profiles - BCIQ
Jan 20, 2022 X-Vax Technology Inc. - BioCentury Company Profiles for the biopharma industrySee details»
X-vax Technology, Inc. - Overview, CEO, Products, Business
X-vax Technology, Inc. is a private company and X-vax Technology, Inc. is classified as a Non Government company. X-vax Technology, Inc. is a Biotechnology based company and has …See details»
X-Vax Technology Raises $56 Million in Upsized Series …
Jul 23, 2019 Proceeds from the financing will be used to advance X-VAX's lead program, a vaccine candidate against herpes, called ∆gD-2 (delta gD-2) for further development and production, including a Phase ...See details»
Research programme: Viral vaccines - X-Vax Technology
Viral, live vaccines are being developed by X-Vax Technology for the prevention of mucosal infections, including herpes simplex virus type 1 (HSV-1) and herpes Research programme: …See details»
Capturing Structural Variants of Herpes Simplex Virus Genome in …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... (10,980,874 and 9,999,665), and is …See details»
X-Vax: Bucking dogma in HSV vaccine development
Oct 3, 2019 X-Vax Technology Inc. COO Andreas Eggert told BioCentury that HSV vaccine R&D has centered on eliciting neutralizing antibodies (nAbs) against glycoprotein D, a protein …See details»
x-vax technology, inc. News & Press Releases | PR Newswire
Jul 23, 2019 News from x-vax technology, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, …See details»
X-Vax Technology Inks $56M Series A - VC News Daily
X-Vax Technology (X-VAX ), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced that it has raised $56 …See details»
A Phase I trial of delta-gD-2 (herpes vaccine) - AdisInsight - Springer
23 Jul 2019 According to an X-Vax Technology media release, ... Contacting your organization’s admin about adding this content to your AdisInsight subscription Buying a PDF version of any …See details»
X-VAX Technology - Raised $56.5M Funding from 11 investors
Dec 6, 2024 X-VAX Technology has raised a total funding of $56.5M over 1 round from 11 investors. Investors include Founders Fund, Alexandria and 9 others. Their latest funding …See details»
X-VAX Technology - Company Profile - Tracxn
Nov 1, 2024 X-VAX Technology - Developer of virus-based vaccines for treating herpes. This company is not active anymore. Raised a total funding of $56.5M over 1 round from 11 …See details»
X-VAX Technology competitors and alternatives - Tracxn
Oct 20, 2024 X-VAX Technology has 5826 competitors, of which 4679 are active, 1435 are funded and 940 have exited. Who are the newest competitors of X-VAX Technology ? The …See details»